Why the study?
Does lipid modification reduce heart failure incidence?
Does lipid modification reduce heart failure incidence?
Dyslipidemia is associated with an increased risk of heart failure independent of myocardial infarction, suggesting a potential role for lipid modification in heart failure prevention.
Answers are grounded in this paper and cite their sources.
Dyslipidemia-HF association independent of MI is hypothesis-generating; randomized trials needed before considering lipid modification for HF prevention.
Dyslipidemia carries HF risk independent of its association with myocardial infarction, suggesting that lipid modification may be a means for reducing HF risk.
No takes yet. Share an insight, caveat, or question.
Velagaleti et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: